BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
|
Back to Search Results |
|
Model Number 24653 |
Device Problems
Difficult to Remove (1528); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/19/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that it was difficult to remove the stent delivery system from the patient.An eluvia eu, 6x120, 130 cm was selected for use in the superficial femoral artery (sfa) for the percutaneous angioplasty procedure.The target lesion was reported to be 90 percent stenosed, with moderate tortuosity and calcification.The target lesion was predilated prior to stent placement.After successfully deploying the stent in the sfa, the delivery system was attempted to be withdrawn, but it interfered with the 0.014 in micro guidewire, making removal difficult.The micro guidewire was removed first in order to proceed with the procedure.The procedure was completed and there were no adverse consequences reported to the patient.
|
|
Manufacturer Narrative
|
Device media analysis: returned product consisted of an eluvia self-expanding stent system from batch 29133956 with an unknown 0.014 in.Guidewire stuck in the device.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed that the sheath was kinked at the nosecone.Microscopic examination revealed no additional damages.The stent was deployed and did not return for analysis.The handle was x-rayed, and the proximal inner was prolapsed.Inspection of the remainder of the device, revealed no other damage or irregularities.In addition to the device analysis becoming available, additional information was provided regarding the device lot number and the origin of the micro guidewire.Sections b5 and d4 have been updated.
|
|
Event Description
|
It was reported that it was difficult to remove the stent delivery system from the patient.An eluvia eu, 6x120, 130 cm was selected for use in the superficial femoral artery (sfa) for the percutaneous angioplasty procedure.The target lesion was reported to be 90 percent stenosed, with moderate tortuosity and calcification.The target lesion was predilated prior to stent placement.After successfully deploying the stent in the sfa, the delivery system was attempted to be withdrawn, but it interfered with the 0.014 in non-bsc micro guidewire, making removal difficult.The micro guidewire was removed first in order to proceed with the procedure.The procedure was completed and there were no adverse consequences reported to the patient.
|
|
Search Alerts/Recalls
|
|
|